jessica

36 POSTS 0 COMMENTS

Percutaneous PNS may hold the potential to shift the chronic pain...

A recent study demonstrates the potential value of percutaneous peripheral nerve stimulation (PNS) for chronic low back pain. Data reported by Christopher A. Gilmore...

Favourable revascularisation rates for first-in-man results of the Versi Retriever in...

First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...

Nuvectra receives full-body MR-conditional CE Mark approval for Algovita

Nuvectra has announced that it has received full-body MR-conditional approval for the Company’s Algovita spinal cord stimulation (SCS) system from its European Notified Body,...

Nuvectra receives FDA head-only MR-conditional approval for Algovita

Nuvectra has announced that it has received US Food and Drug Administration (FDA) head-only MR-conditional approval for the company’s Algovita spinal cord stimulation (SCS) system. Scott...

InSightec receives CE Mark for Exablate Neuro for Siemens Healthineers MRI...

New magnetic resonance imaging (MRI) compatibility holds potential to expand patient access around the world to incisionless brain surgery. Siemens Healthineers and InSightec have...

Medical attention seeking for TIAs and minor stroke after the ‘Act...

Standing in stark contrast to the public’s response to major stroke, the extensive FAST-based public education campaign has not improved the response to transient...

Good news for gamblers: Transcranial direct current stimulation found to enhance...

Transcranial direct current stimulation (tDCS) offers a novel intervention for individuals with gambling disorder, concluded a recent study that found that its use enhanced...

The evolving role of telemedicine in acute stroke treatment

Amid the current modernisation of ischaemic stroke treatment, Michael Chen discusses how telemedicine not only has tremendous value, but should become a more standard...

Positive results published on the acute treatment of migraine using the...

Cephalalgia, the official peer-reviewed medical journal of the International Headache Society, has published positive results of the American multicentric clinical trial ACME (Acute migraine...

Mainstay Medical announces headline results from ReActiv8-B clinical study

Mainstay Medical International, a medical device company focused on commercialising ReActiv8, an implantable restorative neurostimulation system designed to treat an underlying cause of disabling...

Viz.ai and NICO announce collaboration to speed patient recruitment in the...

Viz.ai and NICO have announced a collaboration to incorporate a new innovative clinical trial recruitment software from Viz.ai into the seminal ENRICH study which...

New approvals allow chronic pain sufferers to try Abbott’s non-opioid pain...

Abbott has announced the launch of the new dorsal root ganglion (DRG) Invisible Trial System, which is approved by the US Food and Drug...

New results demonstrate ability to automatically detect suspected large-vessel occlusion stroke...

Viz.ai has further advanced the field of stroke imaging and workflow by developing a novel method for the detection of signs of large vessel...

Viz.ai designated as American Heart Association/American Stroke Association Get With the...

Viz.ai, an applied artificial intelligence company, has been designated as a compatible vendor for the American Heart Association/American Stroke Association Get With The Guidelines...

iSchemaView RAPID integrates with Join, Allm’s medical communications platform

iSchemaView has announced that the RAPID platform is now compatible with Join, a medical communication app developed by Allm, a multinational developer of mobile...

First use of SPRINT endura peripheral nerve stimulation system to treat...

SPR Therapeutics has announced that Marc Huntoon, director of pain management at the Neuroscience, Orthopaedic and Wellness Center, VCU Medical Center, was the first...

First patients enrolled in CERUS study to treat intracranial aneurysms using...

Cerus Endovascular has announced enrolment of the first patients in the CERUS study (Contour Neurovascular System European Pre-Market Unruptured Aneurysm Study). The CERUS study...

New data shows positive outcomes for the NeuroBlate laser system for...

Monteris Medical, a company specialising in minimally invasive, image-guided laser ablation systems, has announced that the favourable results of its Laser ablation after stereotactic...

Canadian-led international study shows huge costs of delayed access to stroke...

It has been known for years that it is important to get stroke patient’s treatment as soon as possible to increase their chances of...

Stimwave receives FDA clearance for first Wireless SCS System with iPhone-iWatch...

Stimwave Technologies has announced that it has received US Food and Drug Administration (FDA) clearance for the WaveCrest Mobile iOS platform patient controllers for...

New nanomaterial could enable early detection and diagnosis of Alzheimer’s disease

Researchers from Hong Kong Baptist University (HKBU) have discovered a new nanomaterial which could enable the early detection and diagnosis of Alzheimer’s disease.  The image...

FDA approves new SynchroMed II myPTM Personal Therapy Manager that enables...

Medtronic has announced US Food and Drug Administration (FDA) approval of the new SynchroMed II myPTM Personal Therapy Manager for patients with chronic pain....

Acandis receives European CE mark approval for its ACCERO stent

Acandis has announced that it has received European CE mark approval for its ACCERO stent, which is now available for sale in Europe. The...

Monteris Medical announces FDA clearance of NeuroBlate Optic laser probe

Monteris Medical has announced it has received clearance from the US Food and Drug Administration (FDA) for its NeuroBlate Optic laser probe, a laser...

Biogen advances research to improve outcomes for patients with multiple sclerosis

Through its research initiatives, Biogen aims to identify new ways to manage and monitor multiple sclerosis (MS) disease progression and provide physicians with...

Medtronic launches the Control Workflow to help eliminate oral opioids and...

Medtronic logo
Medtronic has announced the US launch of the Control Workflow, an evidence-based approach for use with the SynchroMed II intrathecal drug delivery system ("Medtronic...

NeuroNews Issue 31 – US Edition

In this issue: SCENT trial leads to first ever indication of flow diverter to treat challenging aneurysms Evidence in favour of DRG stimulation builds...

NeuroNews Issue 31

In this issue: SCENT trial leads to first ever indication of flow diverter to treat challenging aneurysms Evidence in favour of DRG stimulation builds...

SPR Therapeutics awarded US$10M to develop its SPRINT peripheral nerve stimulation...

SPR Therapeutics has been awarded two new grants and one new contract from the US Department of Defense totalling US$10M to further develop its...

First intracranial aneurysm patients treated with BRAVO Flow Diverter

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...

SPR Therapeutics announces first use of SPRINT extensa dual-lead peripheral nerve...

SPR Therapeutics, a developer of neurostimulation technology for pain management, has announced that Christopher Gilmore of Carolinas Pain Institute was the first to use...

Largest ever study of depression and anxiety to transform mental health...

Researchers at King’s College London are launching the largest ever single study of depression and anxiety. By recruiting at least 40,000 people in England...

Vesalio initiates full commercial launch of NeVa

  NeVa next-generation neurothrombectomy system Vesalio has announced that it has initiated the full commercial European launch of its NeVa neurothrombectomy platform at the 10th annual...

Innovative on-ambulance PHAST-TSC trial for treatment of acute stroke approved by...

Diffusion Pharmaceuticals, a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where...

Phase 2 trial of novel treatment for ischaemic stroke initiated

Thrombolytic Science (TSI) has announced initiation of a phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of...

Greater obliteration and less in-stent stenosis after ATLAS stent coiling as...

According to research published in the Journal of NeuroIntervential Surgery, Atlas stent-assisted coiling outperformed LVIS Jr in terms of greater obliteration rates and lower...